KLIKJARO (tirzepatide) is a dual agonist targeting the GLP-1 and GIP receptors, formulated to support effective weight management and improved glucose regulation. By activating these complementary metabolic pathways, it helps modulate appetite, enhance insulin sensitivity, and optimize energy utilization—delivering a balanced, controlled, and sustainable metabolic support experience.

Product Care

Pre-filled research pen supplied in a sealed format for laboratory and R&D use only. Supports formulation assessment, compound stability testing, and delivery system evaluation. How to Use the Pen (Quick Guide) • Wash hands thoroughly before use. • Remove cap, check solution is clear, and attach a new needle. • Prime the pen to remove air. • Select the dose using the dial and confirm in the display window. • Inject at a 90° angle into the abdomen, thigh, or upper arm. • Hold for 5–10 seconds, then remove and safely dispose of the needle. Rotate injection sites weekly. Dosing Overview Start low and increase gradually as needed. Research Use Only.